Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment
- PMID: 16095934
- DOI: 10.1016/j.ejpain.2005.06.009
Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment
Abstract
This large scale computer-assisted telephone survey was undertaken to explore the prevalence, severity, treatment and impact of chronic pain in 15 European countries and Israel. Screening interviews identified respondents aged 18 years with chronic pain for in-depth interviews. 19% of 46,394 respondents willing to participate (refusal rate 46%) had suffered pain for 6 months, had experienced pain in the last month and several times during the last week. Their pain intensity was 5 on a 10-point Numeric Rating Scale (NRS) (1 = no pain, 10 = worst pain imaginable) during last episode of pain. In-depth interviews with 4839 respondents with chronic pain (about 300 per country) showed: 66% had moderate pain (NRS = 5-7), 34% had severe pain (NRS = 8-10), 46% had constant pain, 54% had intermittent pain. 59% had suffered with pain for two to 15 years, 21% had been diagnosed with depression because of their pain, 61% were less able or unable to work outside the home, 19% had lost their job and 13% had changed jobs because of their pain. 60% visited their doctor about their pain 2-9 times in the last six months. Only 2% were currently treated by a pain management specialist. One-third of the chronic pain sufferers were currently not being treated. Two-thirds used non-medication treatments, e.g,. massage (30%), physical therapy (21%), acupuncture (13%). Almost half were taking non-prescription analgesics; 'over the counter' (OTC) NSAIDs (55%), paracetamol (43%), weak opioids (13%). Two-thirds were taking prescription medicines: NSAIDs (44%), weak opioids (23%), paracetamol (18%), COX-2 inhibitors (1-36%), and strong opioids (5%). Forty percent had inadequate management of their pain. Interesting differences between countries were observed, possibly reflecting differences in cultural background and local traditions in managing chronic pain.
Conclusions: Chronic pain of moderate to severe intensity occurs in 19% of adult Europeans, seriously affecting the quality of their social and working lives. Very few were managed by pain specialists and nearly half received inadequate pain management. Although differences were observed between the 16 countries, we have documented that chronic pain is a major health care problem in Europe that needs to be taken more seriously.
Similar articles
-
Prevalence of chronic pain, impact on daily life, and treatment practices in India.Pain Pract. 2014 Feb;14(2):E51-62. doi: 10.1111/papr.12132. Epub 2013 Dec 4. Pain Pract. 2014. PMID: 24304963
-
Pain among children and adolescents: restrictions in daily living and triggering factors.Pediatrics. 2005 Feb;115(2):e152-62. doi: 10.1542/peds.2004-0682. Pediatrics. 2005. PMID: 15687423
-
Profiles of pain in Mississippi: results from the Southern Pain Prevalence Study.J Miss State Med Assoc. 2005 Oct;46(10):301-9. J Miss State Med Assoc. 2005. PMID: 16295296
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
The management of chronic pain in important patient subgroups.Clin Drug Investig. 2012 Feb;32 Suppl 1:35-44. doi: 10.2165/11630060-000000000-00000. Clin Drug Investig. 2012. PMID: 23389874 Review.
Cited by
-
Internet-based cognitive behavioural therapy for insomnia comorbid with chronic benign pain - A randomized controlled trial.Internet Interv. 2024 Oct 14;38:100781. doi: 10.1016/j.invent.2024.100781. eCollection 2024 Dec. Internet Interv. 2024. PMID: 39498476 Free PMC article.
-
Pain reduction induced by tapentadol in patients with musculoskeletal chronic pain fosters better sleep quality.Drugs Context. 2021 Apr 19;10:2020-12-9. doi: 10.7573/dic.2020-12-9. eCollection 2021. Drugs Context. 2021. PMID: 33953781 Free PMC article.
-
Portuguese Family Physicians' Perceptions on Pain Management-A Qualitative Study Protocol.Int J Environ Res Public Health. 2022 Nov 10;19(22):14792. doi: 10.3390/ijerph192214792. Int J Environ Res Public Health. 2022. PMID: 36429509 Free PMC article.
-
Metamizole relieves pain by influencing cytokine levels in dorsal root ganglia in a rat model of neuropathic pain.Pharmacol Rep. 2020 Oct;72(5):1310-1322. doi: 10.1007/s43440-020-00137-8. Epub 2020 Jul 20. Pharmacol Rep. 2020. PMID: 32691345 Free PMC article.
-
Animal models for the study of depressive disorder.CNS Neurosci Ther. 2021 Jun;27(6):633-642. doi: 10.1111/cns.13622. Epub 2021 Mar 1. CNS Neurosci Ther. 2021. PMID: 33650178 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials